TheJobsMapSigilon Therapeutics jobs and careers
Cambridge, MA, United States
About Sigilon Therapeutics
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
Founded in 2015 by Arturo Vegas, Daniel Anderson, José Oberholzer, Omid Veiseh and Robert Langer.
- Founded
- 2015
- Employees
- 125
- Total funding
- $263.2M
- Headquarters
- Cambridge
Leadership
The top of Sigilon Therapeutics's org chart, with how many people report into each leader.
Rogerio Vivaldi
President & CEO
14 reports
Sarah Yuan
Chief Technical Operations Officer
4 reports
Jiang Wu
VP & Head, Bioanalytical & CMC Analytical Development
3 reports
Omid Veiseh
Co-founder
Jamie M.
VP Of Finance & Controller
Jamie Murphy
VP, Finance & Controller
Joseph Tumang
VP & Head, Immune Mediated Diseases
Olivia G. Kelly
Vice President, Islet Cell Therapy Research
Board
Ulrik B. Nielsen
Advisor
Robert Langer
Advisor
Arturo Vegas
Founder
Michael Rosenblatt
Advisor
Constance Cepko
Advisor
Daniel G. Anderson
Founder & Scientific Advisor
Jobs at Sigilon Therapeutics
No open positions right now. Explore more companies on TheJobsMap.